BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31292115)

  • 41. Transformation of FL into DLBCL with a PMBL gene expression signature.
    Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
    Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
    Karube K; Enjuanes A; Dlouhy I; Jares P; Martin-Garcia D; Nadeu F; Ordóñez GR; Rovira J; Clot G; Royo C; Navarro A; Gonzalez-Farre B; Vaghefi A; Castellano G; Rubio-Perez C; Tamborero D; Briones J; Salar A; Sancho JM; Mercadal S; Gonzalez-Barca E; Escoda L; Miyoshi H; Ohshima K; Miyawaki K; Kato K; Akashi K; Mozos A; Colomo L; Alcoceba M; Valera A; Carrió A; Costa D; Lopez-Bigas N; Schmitz R; Staudt LM; Salaverria I; López-Guillermo A; Campo E
    Leukemia; 2018 Mar; 32(3):675-684. PubMed ID: 28804123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
    Donzel M; Pesce F; Trecourt A; Groussel R; Bachy E; Ghesquières H; Fontaine J; Benzerdjeb N; Mauduit C; Traverse-Glehen A
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.
    Sakakibara A; Kohno K; Iwakoshi A; Moritani S; Fujishiro A; Kito K; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
    Pathol Int; 2020 Feb; 70(2):116-122. PubMed ID: 31894883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The molecular pathogenesis of primary mediastinal large B-cell lymphoma.
    Steidl C; Gascoyne RD
    Blood; 2011 Sep; 118(10):2659-69. PubMed ID: 21700770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma.
    Badri N; Ngamdu KS; Torabi A; Guar S
    J Cancer Res Ther; 2020; 16(1):183-185. PubMed ID: 32362635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
    Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
    J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathobiology of primary mediastinal B-cell lymphoma.
    Pileri SA; Zinzani PL; Gaidano G; Falini B; Gaulard P; Zucca E; Sabattini E; Ascani S; Rossi M; Cavalli F;
    Leuk Lymphoma; 2003; 44 Suppl 3():S21-6. PubMed ID: 15202521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Report: workshop on mediastinal grey zone lymphoma.
    Poppema S; Kluiver JL; Atayar C; van den Berg A; Rosenwald A; Hummel M; Lenze D; Lammert H; Stein H; Joos S; Barth T; Dyer M; Lichter P; Klein U; Cattoretti G; Gloghini A; Tu Y; Stolovitzky GA; Califano A; Carbone A; Dalla-Favera R; Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Eur J Haematol Suppl; 2005 Jul; (66):45-52. PubMed ID: 16007868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation
    Burkhard R; Keller I; Arambasic M; Juskevicius D; Tzankov A; Lundberg P; Bruggmann R; Dirnhofer S; Radpour R; Novak U
    Haematologica; 2019 Apr; 104(4):766-777. PubMed ID: 30381301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
    Eberle FC; Salaverria I; Steidl C; Summers TA; Pittaluga S; Neriah SB; Rodriguez-Canales J; Xi L; Ylaya K; Liewehr D; Dunleavy K; Wilson WH; Hewitt SM; Raffeld M; Gascoyne RD; Siebert R; Jaffe ES
    Mod Pathol; 2011 Dec; 24(12):1586-97. PubMed ID: 21822207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
    Chen BJ; Ruminy P; Roth CG; Bisig B; Mankel B; Steinhilber J; Bohers E; Jardin F; Fend F; Swerdlow SH; Copie-Bergman C; de Leval L; Quintanilla-Martinez L
    Am J Surg Pathol; 2019 Jan; 43(1):110-120. PubMed ID: 30211726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.
    Copie-Bergman C; Boulland ML; Dehoulle C; Möller P; Farcet JP; Dyer MJ; Haioun C; Roméo PH; Gaulard P; Leroy K
    Blood; 2003 Apr; 101(7):2756-61. PubMed ID: 12446450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
    Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
    Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.
    Shi M; Roemer MG; Chapuy B; Liao X; Sun H; Pinkus GS; Shipp MA; Freeman GJ; Rodig SJ
    Am J Surg Pathol; 2014 Dec; 38(12):1715-23. PubMed ID: 25025450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
    Miloudi H; Leroy K; Jardin F; Sola B
    Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
    Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
    Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinicopathological features and prognosis of primary mediastinal large B-cell lymphoma: a series of sixty cases].
    Liu HY; Zhong RQ; Zhang KP; Zhu TN; Zhong DR
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1139-1144. PubMed ID: 34619867
    [No Abstract]   [Full Text] [Related]  

  • 59. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
    Mansouri L; Noerenberg D; Young E; Mylonas E; Abdulla M; Frick M; Asmar F; Ljungström V; Schneider M; Yoshida K; Skaftason A; Pandzic T; Gonzalez B; Tasidou A; Waldhueter N; Rivas-Delgado A; Angelopoulou M; Ziepert M; Arends CM; Couronné L; Lenze D; Baldus CD; Bastard C; Okosun J; Fitzgibbon J; Dörken B; Drexler HG; Roos-Weil D; Schmitt CA; Munch-Petersen HD; Zenz T; Hansmann ML; Strefford JC; Enblad G; Bernard OA; Ralfkiaer E; Erlanson M; Korkolopoulou P; Hultdin M; Papadaki T; Grønbæk K; Lopez-Guillermo A; Ogawa S; Küppers R; Stamatopoulos K; Stavroyianni N; Kanellis G; Rosenwald A; Campo E; Amini RM; Ott G; Vassilakopoulos TP; Hummel M; Rosenquist R; Damm F
    Blood; 2016 Dec; 128(23):2666-2670. PubMed ID: 27670424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 27 cases].
    Shi QY; Feng X; Chen H; Ma HH; Lu ZF; Shi QL; Zhou XJ; Shen Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):607-612. PubMed ID: 28910870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.